South San Francisco, CA, United States of America

Paul E Carrington

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Rahway, NJ (US) (2017)
  • Hillsborough, NJ (US) (2020)
  • South San Francisco, CA (US) (2019 - 2022)
  • San Mateo, CA (US) (2019 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Paul E Carrington: Innovator in Antibody Peptide Conjugates

Introduction

Paul E Carrington is a notable inventor based in South San Francisco, CA. He holds a total of seven patents, showcasing his significant contributions to the field of biochemistry and metabolic disorder treatments. His work primarily focuses on developing innovative therapeutic solutions.

Latest Patents

Among his latest patents, Carrington has developed antibody peptide conjugates that exhibit agonist activity at both the glucagon and glucagon-like peptide 1 receptors. These conjugates are designed to be resistant to cleavage and inactivation by dipeptidyl peptidase IV (DPP-IV), thereby increasing the in vivo half-life of the peptide analog. This advancement enables the peptide analog to effectively treat metabolic disorders such as diabetes, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and obesity. Additionally, he has worked on long-acting co-agonists of the glucagon and GLP-1 receptors, further enhancing therapeutic options in this area.

Career Highlights

Carrington has had a distinguished career, working with prominent companies such as Merck Sharp & Dohme Corporation and MSD Italia S.r.l. His expertise and innovative approach have made a significant impact in the pharmaceutical industry.

Collaborations

Throughout his career, Carrington has collaborated with esteemed colleagues, including Elisabetta Bianchi and Antonello Pessi. These partnerships have contributed to the advancement of his research and the development of groundbreaking therapies.

Conclusion

Paul E Carrington's work in the field of antibody peptide conjugates and metabolic disorder treatments highlights his role as a leading inventor. His contributions continue to pave the way for innovative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…